| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3.39% | 205.41% | 211.01% | 67/138 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.09% | 212.37% | 166.87% | 83/138 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -1.63% | 11.89% | -150% | 122/138 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.26% | -38.95% | 193.69% | 77/138 | 3.05% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 1.11% | -69.67% | 214.43% | 95/138 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.97% | -191.51% | 47.57% | 112/138 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -1.85% | -76.19% | -134.64% | 120/138 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 5.34% | -9.64% | 45.9% | 68/138 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.66% | -5.18% | 245.28% | 79/138 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.06% | 10.42% | 200.95% | 99/138 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | -1.05% | -50% | -117.77% | 117/138 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 5.91% | -58.47% | 53.11% | 90/138 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 3.86% | -34.8% | 302.08% | 93/138 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 0.96% | -28.36% | 237.14% | 107/138 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | -0.7% | 2% | -104.92% | 104/138 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 14.23% | 35.52% | 140.37% | 59/138 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 5.92% | 2% | 341.79% | 87/138 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 1.34% | -49.05% | -87.24% | 110/138 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 10.5% | -21.29% | 299.24% | 86/138 | 25.47% | 热景生物 | 57.63% | 行业排名> |
| 2020-06-30 | 2.63% | 2% | -80.28% | 92/138 | 15.03% | 中红医疗 | 168% | 行业排名> |
| 2019-12-31 | 13.34% | 85.79% | 85.79% | 60/138 | 14.24% | 圣湘生物 | 112.46% | 行业排名> |
| 2018-12-31 | 7.18% | 88.45% | 88.45% | 80/138 | 12.87% | 博拓生物 | 108.13% | 行业排名> |
| 2017-12-31 | 3.81% | 2% | 2% | 85/138 | 13.76% | 圣湘生物 | 29.33% | 行业排名> |

微信公众号
证券之星APP


